Please login to the form below

Not currently logged in
Email:
Password:

PharmaLex strengthens international team

Consultancy group appoints Adrian Pencak

Adrian PencakPharmaLex Group has appointed new executive vice president, business development and marketing in the form of Adrian Pencak.

Pencak joins the German consultancy group following over 25 years’ global business development, marketing and operations experience, spanning the life sciences and healthcare sectors.

He said: “I am very excited to have joined the PharmaLex management team as we are a company with ambitious growth targets as well as extremely high standards of services.

“I’m looking forward to playing a key role in our continued growth and success, with a special focus on the US.”

He joins the group from ICON, where he was vice president, global business development early phase services.

Dr Thomas Dobmeyer, chief executive officer at PharmaLex, said: “Adrian’s appointment demonstrates our commitment to developing our global infrastructure and sales.

“Alongside his strong business development experience, Adrian’s background in the IT space will also support our artificial intelligence and innovative led services.”

24th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics